Troxerutin

DB13124InvestigationalSmall molecule

Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.

Chemical structure of Troxerutin
Mechanism
Curator reviewed
Formula / weight
C33H42O19 · 742.6752 g/mol (avg)

Resolves to

Compound
UNII7Y4N11PXO8CAS7085-55-4ChEMBLCHEMBL3182320PubChem5486699
Clinical / RWD
RxNorm38893ATCC05CA04ATCC05CA54
Structure
InChIKeyIYVFNTXFRYQLRP-VVSTWUKXSA-NSMILESC[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(OCCO)=CC(O)=C4C3=O)C3=CC(OCCO)=C(OCCO)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
Targets
P22303ACHE

What you can answer from here — as of July 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
641Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
20Marketed productsAcross 6 countries and 10 labellers
Sign in
2ATC codesIncluding every combination product, plus 10 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Troxerutin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In